KLS Keeping Law Simple Legislation in plain English

Straight-ahead summaries built from the official bill text. We keep the source links front and center and leave the decision up to you.

Back to Maine

LD582 • 2025

An Act to Require Health Insurance Carriers to Provide Coverage for Blood Testing for Perfluoroalkyl and Polyfluoroalkyl Substances

An Act to Require Health Insurance Carriers to Provide Coverage for Blood Testing for Perfluoroalkyl and Polyfluoroalkyl Substances

Enacted

This bill passed the Legislature and reached final enactment based on the latest official action.

Sponsor
Senator Stacy Brenner
Last action
2026-04-15
Official status
Signed by the Governor
Effective date
Not listed

Plain English Breakdown

Using official source text because the generated explanation was unavailable or could not be confirmed against the official bill text.

An Act to Require Health Insurance Carriers to Provide Coverage for Blood Testing for Perfluoroalkyl and Polyfluoroalkyl Substances

An Act to Require Health Insurance Carriers to Provide Coverage for Blood Testing for Perfluoroalkyl and Polyfluoroalkyl Substances Sponsor: Senator Stacy Brenner Reference committee: Health Coverage, Insurance and Financial Services Governor action: Signed by the Governor

What This Bill Does

  • An Act to Require Health Insurance Carriers to Provide Coverage for Blood Testing for Perfluoroalkyl and Polyfluoroalkyl Substances Sponsor: Senator Stacy Brenner Reference committee: Health Coverage, Insurance and Financial Services Governor action: Signed by the Governor

Limits and Unknowns

  • This entry is temporarily using official source text because the generated explanation could not be confirmed against the official bill text during the last sync.

Amendments

These notes stay tied to the official amendment files and metadata from the legislature.

Adopted by House & Senate

Plain English: Page 1 - 132LR0980(02) COMMITTEE AMENDMENT 1 L.D.

  • Page 1 - 132LR0980(02) COMMITTEE AMENDMENT 1 L.D.
  • 582 2 Date: (Filing No.
  • S- ) 3HEALTH COVERAGE, INSURANCE AND FINANCIAL SERVICES 4 Reproduced and distributed under the direction of the Secretary of the Senate.
  • 5STATE OF MAINE 6SENATE 7132ND LEGISLATURE 8FIRST SPECIAL SESSION 9 COMMITTEE AMENDMENT “ ” to S.P.

Bill History

  1. 2026-04-15 Governor

    Signed by the Governor

  2. 2026-04-13 Senate

    On motion by Senator ROTUNDO of Androscoggin taken from the Special Appropriations Table. Subsequently, PASSED TO BE ENACTED in concurrence.

  3. 2025-05-20 House

    PASSED TO BE ENACTED . Sent for concurrence. ORDERED SENT FORTHWITH.

  4. 2025-05-08 Committee

    Reported Out; OTP-AM/ONTP

  5. 2025-03-12 Committee

    Work Session Held

  6. 2025-03-12 Committee

    Voted; Divided Report

  7. 2025-02-19 Committee

    Referred to Committee on Health Coverage, Insurance and Financial Services.

Official Summary Text

An Act to Require Health Insurance Carriers to Provide Coverage for Blood Testing for Perfluoroalkyl and Polyfluoroalkyl Substances
Sponsor:
Senator Stacy Brenner
Reference committee:
Health Coverage, Insurance and Financial Services
Governor action:
Signed by the Governor

Current Bill Text

Read the full stored bill text 
Page 1 - 132LR0980(03)
STATE OF MAINE
_____
IN THE YEAR OF OUR LORD
TWO THOUSAND TWENTY-FIVE
_____
S.P. 265 - L.D. 582
An Act to Require Health Insurance Carriers to Provide Coverage for Blood
Testing for Perfluoroalkyl and Polyfluoroalkyl Substances
Be it enacted by the People of the State of Maine as follows:
Sec. 1. 24-A MRSA §4320-W is enacted to read:
§4320-W. Coverage for blood testing for PFAS
1. Definition. As used in this section, unless the context otherwise indicates,
"perfluoroalkyl and polyfluoroalkyl substances" or "PFAS" means any member of the class
of fluorinated organic chemicals containing at least one fully fluorinated carbon atom.
2. Required coverage. A carrier offering a health plan in this State shall provide
coverage for blood testing for perfluoroalkyl and polyfluoroalkyl substances that is
recommended by a provider as medically necessary health care for an enrollee. For the
purposes of this subsection, blood testing for PFAS is presumed to be medically necessary
health care for an enrollee if a provider determines that the enrollee meets clinical
guidelines for blood testing for PFAS established by the National Academies of Sciences,
Engineering, and Medicine, its successor organization or a comparable organization.
Sec. 2. Application. This Act applies to all policies, contracts and certificates
executed, delivered, issued for delivery, continued or renewed in this State on or after
January 1, 2027. For purposes of this Act, all contracts are deemed to be renewed no later
than the next yearly anniversary of the contract date.
Sec. 3. Exemption from mandate review. Notwithstanding the Maine Revised
Statutes, Title 24-A, section 2752, this Act is enacted without review and evaluation by the
Department of Professional and Financial Regulation, Bureau of Insurance.
Sec. 4. Appropriations and allocations. The following appropriations and
allocations are made.
ADMINISTRATIVE AND FINANCIAL SERVICES, DEPARTMENT OF
State Benefit Mandate Defrayal Z373
APPROVED
APRIL 15, 2026
BY GOVERNOR
CHAPTER
710
PUBLIC LAW
Page 2 - 132LR0980(03)
Initiative: Provides ongoing funding for the cost of the benefit mandate providing coverage
of blood testing for perfluoroalkyl and polyfluoroalkyl substances, beginning January 1,
2027.
GENERAL FUND 2025-26 2026-27
All Other $0 $90,000
__________ __________
GENERAL FUND TOTAL $0 $90,000